Development, validation, utility and economic assessment of a flexible, individualized risk prediction e-tool for exacerbation in patients with severe asthma (Severe asthma risk prediction)

04/03/2022
04/03/2022
EU PAS number:
EUPAS46088
Study
Planned
Documents
Study protocol
Study results
Study report
Other information